This website is intended for a U.S. audience only
Aimmune is a leader in developing treatments designed to reduce the
frequency and severity of allergic reactions.
We're on a mission to transform the lives of millions of people who live with serious food allergies.
Recent News
European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU
December 21, 2020
Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe
October 16, 2020
Nestlé Completes Acquisition of Aimmune Therapeutics
October 14, 2020
Pipeline
See the Future
We are targeting prevalent food allergies, and you’re invited to experience it yourself.
See what's happing at aimmune
Careers
Join Our Team
We’re building a team that aims to transform how food allergies are treated. Learn more about our company and explore current openings.
Careers at Aimmune